Services

EnquBio's Comprehensive Drug Discovery Solutions & Services

At EnquBio, our expert team delivers high quality, efficient, and dependable R&D solutions that enable pharmaceutical and biotech partners to advance and expand their drug development pipelines.

Tissue-Based Ex Vivo & Primary Cell Models

Use fresh tissue and primary-cell preparations to study tissue-specific pharmacology in biologically relevant systems.

EnquBio supports customized tissue processing, primary-cell isolation, short-term culture and ex vivo pharmacology workflows for selected tissues. Study designs are tailored to tissue source, cell viability, target biology, assay feasibility and the biological question being addressed.

Tissue-Based Ex Vivo & Primary Cell Models

Tissue- and Primary-Cell Models for Translational Pharmacology

Fresh tissues can be processed into fit-for-purpose primary-cell or short-term ex vivo systems to interrogate tissue-specific biology.

Fresh Tissue

Start with biologically relevant material

Use freshly collected animal or human tissue where appropriate to preserve disease- or organ-relevant biology.

Primary Cells

Isolate relevant cell populations

Generate primary-cell preparations for controlled functional and pharmacodynamic studies.

Fit-for-Purpose

Build around the biological question

Select processing, culture and endpoints based on tissue source, viability, target biology and study objective.

Representative Tissue Systems

Available models are selected project by project based on tissue source and feasibility.

CNS / Brain-Derived

  • Microglia
  • Neuron-related preparations
  • Brain-derived primary cells
  • Inflammatory / signaling readouts

Immune Tissues

  • Spleen
  • Splenocytes
  • Lymphoid populations
  • Ex vivo stimulation assays

Liver-Derived

  • Hepatocyte-related workflows
  • Liver-derived cell preparations
  • Target / pathway endpoints
  • Functional response

Other Project-Specific Tissues

  • Fresh tissue processing
  • Primary-cell isolation
  • Short-term culture
  • Customized readouts

Typical Workflow

01

Tissue Collection

Fresh tissue collected or received under defined conditions.

02

Processing

Mechanical / enzymatic dissociation or other fit-for-purpose preparation.

03

Cell Enrichment

Enrich relevant primary-cell populations where required.

04

Ex Vivo Treatment

Compound exposure, stimulation or mechanistic challenge.

05

Endpoint Analysis

Functional, cellular, protein and molecular readouts.

Integrated Readouts

Cell ViabilityCulture health and treatment-associated response
Flow CytometryCell identity, phenotype and activation
MSD / ELISASecreted and tissue-associated biomarkers
Jess / WesternProtein expression and signaling
RT-qPCR / ddPCRGene expression and molecular response
Because tissue-derived models are highly source- and tissue-dependent, feasibility and optimization may be incorporated before larger studies.

Have a tissue-specific pharmacology question?

Tell us the tissue source, target biology, available material and desired readouts. We can evaluate feasibility and build a fit-for-purpose ex vivo workflow.

Contact Our Scientists →
Fresh tissue processing and primary-cell isolation
Customized short-term ex vivo studies
Functional, cellular, protein and molecular readouts